Torrent Pharmaceuticals (NSE:TORNTPHARM) E10: ₹43.61 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
89 GF Score
Price ₹4,970.00
GF Value ₹4,991.50
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals E10?

Torrent Pharmaceuticals NSE:TORNTPHARM -0.72% 89 E10 is ₹43.61 as of Jun. 2026. GuruFocus rates NSE:TORNTPHARM with a GF Score™ of 89/100 and a GF Value™ of ₹4,991.50 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Torrent Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹16.724. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹43.61 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Torrent Pharmaceuticals's average E10 Growth Rate was 4.20% per year. During the past 3 years, the average E10 Growth Rate was 5.50% per year. During the past 5 years, the average E10 Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Torrent Pharmaceuticals was 9.00% per year. The lowest was 5.50% per year. And the median was 8.35% per year.

As of today (2026-09-22), Torrent Pharmaceuticals's current stock price is ₹4970.00. Torrent Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 was ₹43.61. Torrent Pharmaceuticals's Shiller PE Ratio of today is 113.97.

During the past 13 years, the highest Shiller PE Ratio of Torrent Pharmaceuticals was 118.04. The lowest was 32.53. And the median was 49.12.


Torrent Pharmaceuticals  (NSE:TORNTPHARM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Torrent Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4970.00/43.608
=113.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Torrent Pharmaceuticals was 118.04. The lowest was 32.53. And the median was 49.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Torrent Pharmaceuticals E10 Related Terms


Torrent Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals E10 Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.41 35.77 38.89 42.08 42.06

Torrent Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.82 42.57 42.44 42.50 43.61

NSE:TORNTPHARM vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Shiller PE Ratio falls into.


NSE:TORNTPHARM
89GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Torrent Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=16.7235/167.3573*167.3573
=16.724

Current CPI (Jun. 2026) = 167.3573.

Torrent Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201609 6.115 105.961 9.658
201612 6.765 105.196 10.763
201703 6.085 105.196 9.681
201706 5.555 107.109 8.679
201709 6.028 109.021 9.253
201712 1.714 109.404 2.621
201803 6.735 109.786 10.267
201806 4.816 111.317 7.241
201809 5.289 115.142 7.687
201812 7.269 115.142 10.565
201903 -4.491 118.202 -6.359
201906 6.382 120.880 8.836
201909 7.209 123.175 9.795
201912 7.416 126.235 9.832
202003 9.278 124.705 12.451
202006 9.485 127.000 12.498
202009 9.160 130.118 11.781
202012 8.775 130.889 11.220
202103 9.573 131.771 12.159
202106 9.751 134.084 12.170
202109 9.337 135.847 11.503
202112 7.357 138.161 8.912
202203 -3.487 138.822 -4.203
202206 10.460 142.347 12.297
202209 9.219 144.661 10.665
202212 8.628 145.763 9.906
202303 8.480 146.865 9.663
202306 11.169 150.280 12.438
202309 11.405 151.492 12.600
202312 13.089 152.924 14.325
202403 13.267 153.035 14.508
202406 13.503 155.789 14.506
202409 13.385 157.882 14.188
202412 14.862 158.323 15.710
202503 14.714 157.552 15.630
202506 16.192 159.755 16.962
202509 17.462 162.289 18.008
202512 18.762 163.281 19.231
202603 11.494 164.272 11.710
202606 16.724 167.357 16.724

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹43.61 mean?
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a E10 of ₹43.61 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' E10 too high?
Torrent Pharmaceuticals' current E10 is ₹43.61. Overall, Torrent Pharmaceuticals has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' E10 compare to ZTS?
Torrent Pharmaceuticals' E10 of ₹43.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current E10 is ₹43.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,991.50, compared to a current price of ₹4,970.00 — trading 0.4% below its estimated fair value. The current E10 is ₹43.61. Torrent Pharmaceuticals' overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current E10 is ₹43.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be undervalued. The current stock price of ₹4,970.00 is trading 0.4% below its estimated GF Value™ of ₹4,991.50. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:TORNTPHARM:

  • E10: ₹43.61
  • GF Value™: ₹4,991.50 vs. price of ₹4,970.00 (0.4% below fair value)
  • GF Score™: 89/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
89GF Score

Get the complete analysis for NSE:TORNTPHARM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,970.00
Price
₹4,991.50
GF Value